• Client Reporting Portal
  • For Managers
  • Contact Us
Xponance | Asset Management and Investment
  • Strategies
    • Multi-Manager Platform
    • Systematic Global Equities
      • Active Strategies
        • Market Plus
        • SMID Cap Core
        • Small Cap Core
      • Passive Strategies
        • S&P 500 Index Replication
        • S&P 400 Index Replication
        • Russell 1000 Index Replication
        • Russell 1000 Growth Index Replication
        • Russell 1000 Value Index Replication
        • Russell 3000 Index Replication
        • MSCI World ex US
        • MSCI USA
      • Values-Based Equity
        • S&P 500 ESG Enhanced
        • S&P 500 DEI & ESG
      • Customized Mission Aligned
        • S&P 500 Catholic Values
    • U.S. Fixed Income
      • Limited Duration
      • Opportunistic Core
      • Intermediate Government/Credit
    • Xponance Alts
    • Values-Based Investing
  • Perspectives
    • Insights
    • Archives
      • Foresights
      • Global Market Outlook Reports
      • Market Insights Alerts
      • Videos And Webinars
  • News
    • Newsroom – Press Releases
    • Media Coverage
  • About Xponance®
    • Company
    • Mission
    • People
      • Executive
      • Investment Leaders
      • Portfolio Operations
      • Corporate
      • Sales & Client Service
      • Xponance Alts
      • Board of Directors
    • Careers
    • Emerging Manager Ecosystem
    • Community Engagement
Select Page

Home » Xponance® Press Release 2023

Xponance Celebrates Five Years of Recognition as a Best Place to Work in Money Management by Pensions & Investments

by Marc Poitevien | Dec 9, 2024 | Xponance® Press Release 2023, Xponance® Press Release

Press Release Philadelphia, PA (Dec. 9, 2024) – Xponance, Inc., a multi-strategy investment firm, was recognized in the 2024 Best Places to Work in Money Management awards announced by Pensions & Investments today. This is the fifth year in a row that the company...

Xponance Alts Solutions Announces Strategic Investment in The Copia Group

by Marc Poitevien | Mar 19, 2024 | Xponance® Press Release 2023

Press Release PHILADELPHIA, March 19, 2024 – Xponance Alts Solutions (“XAlts”), a subsidiary of Xponance Inc, announced today that it has entered into a strategic partnership with private investment firm The Copia Group (“Copia”). XAlts...

Xponance, Inc. Adds Senior Business Development Professional, Sets Sights on Strategic Initiatives for 2023

by Marc Poitevien | Mar 2, 2023 | Xponance® Press Release 2023

Press Release Philadelphia, PA – March 2, 2023 – Xponance, Inc., a leading, diverse, and 100% employee-owned multi-strategy investment firm, announced today that Marcy Rappaport has joined the firm as Director of Business Development and Consultant Relations. Marcy is...

Refine Search:

  • Search Term

  • Author

  • Date Range

Recent Posts

  • Xponance Celebrates Five Years of Recognition as a Best Place to Work in Money Management by Pensions & Investments
  • The Precariat Are Still Mad! Real Talk on Immigration – Part II
  • The Precariat Are Still Mad! An Analysis of 2024’s Incumbent Party Shellacking – Part I
  • Laboring Under Pressure: Are Labor Supply Trends Breeding Long-Term Stagflationary Conditions?
  • Yielding to Temptation: Pigs Get Fat, Hogs Get Slaughtered: Q3 2024 Fixed Income Update

The Xponance Edge

FIS Leadership Team
The FIS Way
Macro Tactical Management

Philadelphia

Headquarters
1845 Walnut Street
Suite 800
Philadelphia PA 19103
215.567.1100

Durham, NC

2605 Meridian Parkway
Suite 105
Durham, NC 27713
919.688.8600

Sign Up For Email Updates

Contact Us

Strategies

Multi-Manager Platform
Systematic Global Equities
U.S. Fixed Income

Perspectives

Insights
Archive Foresight
Archive Global Market Outlook Reports

News

Media Coverage
Press Releases

About Xponance®

Company
Mission
People
Emerging Manager Ecosystem
Community Engagement

Terms of Use | Privacy Policy | Careers | Form CRS | ADV Part 2A | ADV Part 2B | 408(b)(2)

  • Follow
  • Follow
  • Follow

©2006 – 2024, Xponance®, Inc. and/or its predecessor companies; XPONANCE®, TRANSFORMING ACCESS TO ALPHA and AAPRYL® are registered trademarks of Xponance®, Inc. and/or its predecessor companies. All rights reserved.